2024 Q1 Form 10-K Financial Statement

#000138584924000025 Filed on February 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $25.43M $465.0K $37.93M
YoY Change 29.64% 158.33% 203.06%
Cost Of Revenue $11.05M $0.00 $18.18M
YoY Change 33.7% 131.78%
Gross Profit $14.37M $465.0K $19.75M
YoY Change 26.68% 173.53% 322.76%
Gross Profit Margin 56.53% 100.0% 52.06%
Selling, General & Admin $7.939M $7.131M $27.92M
YoY Change 31.81% -16.01% 9.53%
% of Gross Profit 55.23% 1533.55% 141.36%
Research & Development $2.135M $6.099M $15.53M
YoY Change -31.13% 108.87%
% of Gross Profit 14.85% 1311.61% 78.65%
Depreciation & Amortization $670.0K $727.0K $2.750M
YoY Change 1.52% -1.76% -15.9%
% of Gross Profit 4.66% 156.34% 13.93%
Operating Expenses $7.939M $14.82M $27.92M
YoY Change 31.81% 2.0% 9.53%
Operating Profit $2.021M -$14.36M -$32.37M
YoY Change -599.01% -0.03% -27.97%
Interest Expense $1.617M $262.0K $11.71M
YoY Change -202.34% -107.51% -178.92%
% of Operating Profit 80.01%
Other Income/Expense, Net $1.617M -$5.723M $132.4M
YoY Change -98.59% 1230.93% -982.31%
Pretax Income $3.638M -$19.82M $100.0M
YoY Change -96.82% 10.71% -266.88%
Income Tax $276.0K $276.0K
% Of Pretax Income 0.28%
Net Earnings $3.640M -$20.11M $99.76M
YoY Change -96.81% 12.32% -266.42%
Net Earnings / Revenue 14.32% -4323.87% 263.01%
Basic Earnings Per Share $0.02 $0.63
Diluted Earnings Per Share $0.02 -$0.12 $0.62
COMMON SHARES
Basic Shares Outstanding 163.6M shares 161.3M shares 159.1M shares
Diluted Shares Outstanding 164.6M shares 160.2M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $195.6M $190.5M $190.5M
YoY Change 87.51% 153.99% 153.99%
Cash & Equivalents $54.78M $57.45M $57.45M
Short-Term Investments $140.8M $133.0M $133.0M
Other Short-Term Assets $3.394M $2.522M $2.522M
YoY Change -24.58% -88.48% -88.48%
Inventory $32.07M $40.72M $38.87M
Prepaid Expenses $3.394M $2.522M
Receivables $361.0K $406.0K $406.0K
Other Receivables $493.0K $410.0K $410.0K
Total Short-Term Assets $228.1M $232.7M $232.7M
YoY Change 53.15% 71.62% 71.6%
LONG-TERM ASSETS
Property, Plant & Equipment $29.80M $26.12M $146.9M
YoY Change 103.61% 106.31% 50.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.297M $1.356M $1.356M
YoY Change -92.09% -92.97% -92.97%
Other Assets $21.54M $19.43M $19.43M
YoY Change 9.91% -2.36% -2.36%
Total Long-Term Assets $177.7M $169.2M $169.2M
YoY Change -21.55% 22.32% 22.37%
TOTAL ASSETS
Total Short-Term Assets $228.1M $232.7M $232.7M
Total Long-Term Assets $177.7M $169.2M $169.2M
Total Assets $405.8M $401.9M $401.9M
YoY Change 8.08% 46.72% 46.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.389M $1.006M $5.995M
YoY Change 8.94% -72.48% 62.03%
Accrued Expenses $4.137M $4.365M $4.365M
YoY Change 3.42% 32.27% 32.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.526M $10.36M $10.36M
YoY Change 4.21% -44.37% -44.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.57M $12.37M $12.37M
YoY Change 13.25% 13.52% 13.52%
Total Long-Term Liabilities $12.57M $12.37M $12.37M
YoY Change 13.25% 13.52% 13.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.526M $10.36M $10.36M
Total Long-Term Liabilities $12.57M $12.37M $12.37M
Total Liabilities $18.10M $22.73M $26.69M
YoY Change 10.09% -23.03% -20.32%
SHAREHOLDERS EQUITY
Retained Earnings -$352.6M -$356.3M
YoY Change 3.15% -21.89%
Common Stock $738.3M $733.5M
YoY Change 5.65% 5.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $383.7M $375.2M $375.2M
YoY Change
Total Liabilities & Shareholders Equity $405.8M $401.9M $401.9M
YoY Change 8.08% 46.72% 46.75%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $3.640M -$20.11M $99.76M
YoY Change -96.81% 12.32% -266.42%
Depreciation, Depletion And Amortization $670.0K $727.0K $2.750M
YoY Change 1.52% -1.76% -15.9%
Cash From Operating Activities $8.841M -$4.427M -$15.41M
YoY Change -442.81% -81.43% -69.0%
INVESTING ACTIVITIES
Capital Expenditures $7.259M $8.910M $15.44M
YoY Change -70.78% 1072.37% 673.4%
Acquisitions
YoY Change
Other Investing Activities -$7.565M $949.0K $20.86M
YoY Change -229.54% -85.1% -511.38%
Cash From Investing Activities -$14.82M -$7.961M -$23.85M
YoY Change -21.99% -242.16% 237.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.502M 15.38M $30.42M
YoY Change -513.95% 3650.49% 286.47%
NET CHANGE
Cash From Operating Activities $8.841M -4.427M -$15.41M
Cash From Investing Activities -$14.82M -7.961M -$23.85M
Cash From Financing Activities $3.502M 15.38M $30.42M
Net Change In Cash -$2.527M 2.989M -$5.245M
YoY Change -86.65% -116.76% -90.02%
FREE CASH FLOW
Cash From Operating Activities $8.841M -$4.427M -$15.41M
Capital Expenditures $7.259M $8.910M $15.44M
Free Cash Flow $1.582M -$13.34M -$30.85M
YoY Change -105.77% -45.78% -40.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 efr Underutilized Capacity Production Costs Rare Earth Concentrates
UnderutilizedCapacityProductionCostsRareEarthConcentrates
0 usd
CY2022 efr Underutilized Capacity Production Costs Rare Earth Concentrates
UnderutilizedCapacityProductionCostsRareEarthConcentrates
2758000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
18181000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
7844000 usd
CY2022 efr Standby Costs
StandbyCosts
13221000 usd
CY2021 efr Standby Costs
StandbyCosts
9462000 usd
CY2021 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1284000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244409000 usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001385849
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList
http://www.energyfuels.com/20231231#GainOnDisposalOfNonCoreAssets
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-36204
CY2023 dei Entity Registrant Name
EntityRegistrantName
ENERGY FUELS INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1067994
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
225 Union Blvd., Suite 600
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood,
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80228
CY2023 dei City Area Code
CityAreaCode
303
CY2023 dei Local Phone Number
LocalPhoneNumber
974-2140
CY2023 dei Security12b Title
Security12bTitle
Common Shares, no par value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
954990000 usd
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
163570079 shares
CY2023 dei Auditor Name
AuditorName
KPMG LLP
CY2023 dei Auditor Location
AuditorLocation
Denver, CO
CY2023 dei Auditor Firm
AuditorFirmId
185
CY2023 efr Revenues Uranium Concentrates
RevenuesUraniumConcentrates
33278000 usd
CY2022 efr Revenues Uranium Concentrates
RevenuesUraniumConcentrates
0 usd
CY2021 efr Revenues Uranium Concentrates
RevenuesUraniumConcentrates
0 usd
CY2023 efr Revenues Vanadium Concentrates
RevenuesVanadiumConcentrates
871000 usd
CY2022 efr Revenues Vanadium Concentrates
RevenuesVanadiumConcentrates
8778000 usd
CY2021 efr Revenues Vanadium Concentrates
RevenuesVanadiumConcentrates
74000 usd
CY2023 efr Revenues Rare Earth Concentrates
RevenuesRareEarthConcentrates
2848000 usd
CY2022 efr Revenues Rare Earth Concentrates
RevenuesRareEarthConcentrates
2122000 usd
CY2021 efr Revenues Rare Earth Concentrates
RevenuesRareEarthConcentrates
1385000 usd
CY2023 efr Revenues Alternate Feed Materials Processingand Other
RevenuesAlternateFeedMaterialsProcessingandOther
931000 usd
CY2022 efr Revenues Alternate Feed Materials Processingand Other
RevenuesAlternateFeedMaterialsProcessingandOther
1615000 usd
CY2021 efr Revenues Alternate Feed Materials Processingand Other
RevenuesAlternateFeedMaterialsProcessingandOther
1725000 usd
CY2023 us-gaap Revenues
Revenues
37928000 usd
CY2022 us-gaap Revenues
Revenues
12515000 usd
CY2021 us-gaap Revenues
Revenues
3184000 usd
CY2023 efr Costof Revenue Uranium Concentrates
CostofRevenueUraniumConcentrates
15318000 usd
CY2022 efr Costof Revenue Uranium Concentrates
CostofRevenueUraniumConcentrates
0 usd
CY2021 efr Costof Revenue Uranium Concentrates
CostofRevenueUraniumConcentrates
0 usd
CY2023 efr Costof Revenue Applicable To Vanadium Concentrates
CostofRevenueApplicableToVanadiumConcentrates
551000 usd
CY2022 efr Costof Revenue Applicable To Vanadium Concentrates
CostofRevenueApplicableToVanadiumConcentrates
3769000 usd
CY2021 efr Costof Revenue Applicable To Vanadium Concentrates
CostofRevenueApplicableToVanadiumConcentrates
48000 usd
CY2022 efr Cost Of Revenue Rare Earth Concentrates
CostOfRevenueRareEarthConcentrates
1317000 usd
CY2021 efr Cost Of Revenue Rare Earth Concentrates
CostOfRevenueRareEarthConcentrates
1235000 usd
CY2021 efr Underutilized Capacity Production Costs Rare Earth Concentrates
UnderutilizedCapacityProductionCostsRareEarthConcentrates
531000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1814000 usd
CY2023 efr Development Permitting And Land Holding
DevelopmentPermittingAndLandHolding
15531000 usd
CY2022 efr Development Permitting And Land Holding
DevelopmentPermittingAndLandHolding
9346000 usd
CY2021 efr Development Permitting And Land Holding
DevelopmentPermittingAndLandHolding
10750000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-32367000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-44938000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-35425000 usd
CY2023 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
119257000 usd
CY2022 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
366000 usd
CY2021 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
35733000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13142000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15372000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1140000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
132399000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15006000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36873000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100032000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59944000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1448000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
276000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
99756000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-59944000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3889000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-365000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3889000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-365000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63833000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1083000 usd
CY2023 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
99862000 usd
CY2022 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-59849000 usd
CY2021 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1541000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
106000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
95000 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
93000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
99756000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-59944000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1448000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
99862000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-63738000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1176000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
106000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
95000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
93000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
99756000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63833000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1083000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57445000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62820000 usd
CY2023Q4 us-gaap Trading Securities
TradingSecurities
133044000 usd
CY2022Q4 us-gaap Trading Securities
TradingSecurities
12192000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
223000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
223000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
816000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
519000 usd
CY2023Q4 efr Inventory Current
InventoryCurrent
38868000 usd
CY2022Q4 efr Inventory Current
InventoryCurrent
38155000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2522000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9529000 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
0 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
12375000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
232695000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
135590000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
119581000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
83539000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26123000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12662000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1852000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2465000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1219000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1376000 usd
CY2023Q4 us-gaap Investments
Investments
1356000 usd
CY2022Q4 us-gaap Investments
Investments
19329000 usd
CY2023Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1534000 usd
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1537000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
17579000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
17449000 usd
CY2023Q4 us-gaap Assets
Assets
401939000 usd
CY2022Q4 us-gaap Assets
Assets
273947000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10161000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6929000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
199000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59000 usd
CY2023Q4 efr Contract With Customer Liability Held For Sale Current
ContractWithCustomerLiabilityHeldForSaleCurrent
0 usd
CY2022Q4 efr Contract With Customer Liability Held For Sale Current
ContractWithCustomerLiabilityHeldForSaleCurrent
6000000 usd
CY2023Q4 efr Asset Retirement Obligation And Other Liabilities Held For Sale Current
AssetRetirementObligationAndOtherLiabilitiesHeldForSaleCurrent
0 usd
CY2022Q4 efr Asset Retirement Obligation And Other Liabilities Held For Sale Current
AssetRetirementObligationAndOtherLiabilitiesHeldForSaleCurrent
5636000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10360000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18624000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1120000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1319000 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
10922000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
9595000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
332000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2023Q4 us-gaap Liabilities
Liabilities
22734000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
29538000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
162659155 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162659155 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
157682531 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
157682531 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
733450000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
698493000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356258000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-456120000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1946000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1946000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
375246000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
240427000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
3959000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
3982000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
379205000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244409000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
401939000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
273947000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
157546000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1448000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-365000 usd
CY2021 efr Shares Issued For Cash By At The Market Offering
SharesIssuedForCashByAtTheMarketOffering
108653000 usd
CY2021 efr Stock Issuance Costs
StockIssuanceCosts
-2445000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2158000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2290000 usd
CY2021 efr Stock Issued During Period Value Cash Paymentfor Tax Withholding
StockIssuedDuringPeriodValueCashPaymentforTaxWithholding
659000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
26603000 usd
CY2021 efr Adjustmentsto Additional Paidin Capital Shares Issued For Consulting Services
AdjustmentstoAdditionalPaidinCapitalSharesIssuedForConsultingServices
-242000 usd
CY2021 efr Stock Issued During Period Shares Stock Appreciation Rights
StockIssuedDuringPeriodSharesStockAppreciationRights
5643 shares
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
256000 usd
CY2021 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
311000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295526000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-59944000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3889000 usd
CY2022 efr Shares Issued For Cash By At The Market Offering
SharesIssuedForCashByAtTheMarketOffering
8068000 usd
CY2022 efr Stock Issuance Costs
StockIssuanceCosts
-182000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4641000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
753000 usd
CY2022 efr Stock Issued During Period Value Cash Paymentfor Tax Withholding
StockIssuedDuringPeriodValueCashPaymentforTaxWithholding
884000 usd
CY2022 efr Adjustmentsto Additional Paidin Capital Shares Issued For Consulting Services
AdjustmentstoAdditionalPaidinCapitalSharesIssuedForConsultingServices
-205000 usd
CY2022 efr Stock Issued During Period Shares Stock Appreciation Rights
StockIssuedDuringPeriodSharesStockAppreciationRights
3635 shares
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
11000 usd
CY2022 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
126000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
99756000 usd
CY2023 efr Stock Issued During Period Value Cash Paymentfor Tax Withholding
StockIssuedDuringPeriodValueCashPaymentforTaxWithholding
918000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
718000 usd
CY2023 efr Adjustmentsto Additional Paidin Capital Shares Issued For Consulting Services
AdjustmentstoAdditionalPaidinCapitalSharesIssuedForConsultingServices
-252000 usd
CY2023 efr Stock Issued During Period Shares Stock Appreciation Rights
StockIssuedDuringPeriodSharesStockAppreciationRights
267592 shares
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1533000 usd
CY2023 efr Shares Issued For Cash By At The Market Offering
SharesIssuedForCashByAtTheMarketOffering
32545000 usd
CY2023 efr Stock Issuance Costs
StockIssuanceCosts
-732000 usd
CY2023 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
83000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
379205000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
99756000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-59944000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1448000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2751000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3269000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3189000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
4625000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4641000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2158000 usd
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1192000 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1556000 usd
CY2021 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1284000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
431000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2080000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-129000 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
15472000 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-16808000 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
6311000 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-10491000 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
CY2023 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
1141000 usd
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2023 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
119257000 usd
CY2022 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
366000 usd
CY2021 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
35733000 usd
CY2023 efr Debt Securities Fvni Gain Loss
DebtSecuritiesFVNIGainLoss
1430000 usd
CY2022 efr Debt Securities Fvni Gain Loss
DebtSecuritiesFVNIGainLoss
0 usd
CY2021 efr Debt Securities Fvni Gain Loss
DebtSecuritiesFVNIGainLoss
0 usd
CY2023 efr Increase Decreasein Valueof Warrant Liabilities
IncreaseDecreaseinValueofWarrantLiabilities
0 usd
CY2022 efr Increase Decreasein Valueof Warrant Liabilities
IncreaseDecreaseinValueofWarrantLiabilities
0 usd
CY2021 efr Increase Decreasein Valueof Warrant Liabilities
IncreaseDecreaseinValueofWarrantLiabilities
8078000 usd
CY2023 efr Miscellaneous Non Cash Income Expenses
MiscellaneousNonCashIncomeExpenses
84000 usd
CY2022 efr Miscellaneous Non Cash Income Expenses
MiscellaneousNonCashIncomeExpenses
-93000 usd
CY2021 efr Miscellaneous Non Cash Income Expenses
MiscellaneousNonCashIncomeExpenses
-156000 usd
CY2023 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-530000 usd
CY2022 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-456000 usd
CY2021 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
795000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
100000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8571000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3219000 usd
CY2023 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
237000 usd
CY2022 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1837000 usd
CY2021 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1249000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-423000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8886000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
257000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2807000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1671000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2140000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15409000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49702000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29294000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15437000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1996000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1368000 usd
CY2023 efr Purchase Of Mineral Properties
PurchaseOfMineralProperties
6782000 usd
CY2022 efr Purchase Of Mineral Properties
PurchaseOfMineralProperties
0 usd
CY2023 efr Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
22491000 usd
CY2022 efr Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
0 usd
CY2021 efr Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
0 usd
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2554000 usd
CY2023 efr Purchase Of Investments Without A Readily Determinable Fair Value
PurchaseOfInvestmentsWithoutAReadilyDeterminableFairValue
1324000 usd
CY2022 efr Purchase Of Investments Without A Readily Determinable Fair Value
PurchaseOfInvestmentsWithoutAReadilyDeterminableFairValue
0 usd
CY2021 efr Purchase Of Investments Without A Readily Determinable Fair Value
PurchaseOfInvestmentsWithoutAReadilyDeterminableFairValue
0 usd
CY2023 efr Proceeds For Deposits For Assets Held For Sale
ProceedsForDepositsForAssetsHeldForSale
0 usd
CY2022 efr Proceeds For Deposits For Assets Held For Sale
ProceedsForDepositsForAssetsHeldForSale
6000000 usd
CY2021 efr Proceeds For Deposits For Assets Held For Sale
ProceedsForDepositsForAssetsHeldForSale
0 usd
CY2023 efr Disposal On Non Core Assets Investing Activities
DisposalOnNonCoreAssetsInvestingActivities
56875000 usd
CY2022 efr Disposal On Non Core Assets Investing Activities
DisposalOnNonCoreAssetsInvestingActivities
366000 usd
CY2021 efr Disposal On Non Core Assets Investing Activities
DisposalOnNonCoreAssetsInvestingActivities
2000000 usd
CY2023 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
60887000 usd
CY2022 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
0 usd
CY2021 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23853000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7065000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3186000 usd
CY2023 efr Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
31813000 usd
CY2022 efr Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
7886000 usd
CY2021 efr Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
106208000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
918000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
884000 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
538000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
970000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
753000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2375000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9840000 usd
CY2023 efr Payment Tax Withholding Share Based Payment Arrangement Due Upon Exercise Of Award
PaymentTaxWithholdingShareBasedPaymentArrangementDueUponExerciseOfAward
1533000 usd
CY2022 efr Payment Tax Withholding Share Based Payment Arrangement Due Upon Exercise Of Award
PaymentTaxWithholdingShareBasedPaymentArrangementDueUponExerciseOfAward
11000 usd
CY2021 efr Payment Tax Withholding Share Based Payment Arrangement Due Upon Exercise Of Award
PaymentTaxWithholdingShareBasedPaymentArrangementDueUponExerciseOfAward
256000 usd
CY2023 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
83000 usd
CY2022 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
126000 usd
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
311000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30415000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7870000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117940000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-66000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000 usd
CY2023 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
0 usd
CY2022 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
3590000 usd
CY2021 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
0 usd
CY2023 efr Release Of Restricted Cash
ReleaseOfRestrictedCash
-3590000 usd
CY2022 efr Release Of Restricted Cash
ReleaseOfRestrictedCash
0 usd
CY2021 efr Release Of Restricted Cash
ReleaseOfRestrictedCash
0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5245000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52553000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
91837000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80269000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132822000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40985000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75024000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80269000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132822000 usd
CY2023 us-gaap Interest Paid
InterestPaid
186000 usd
CY2022 us-gaap Interest Paid
InterestPaid
25000 usd
CY2021 us-gaap Interest Paid
InterestPaid
54000 usd
CY2023 efr Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
-701000 usd
CY2022 efr Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
161000 usd
CY2021 efr Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
-182000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
205000 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
242000 usd
CY2023 efr Noncash Acquisition Of Convertible Note
NoncashAcquisitionOfConvertibleNote
59457000 usd
CY2022 efr Noncash Acquisition Of Convertible Note
NoncashAcquisitionOfConvertibleNote
0 usd
CY2021 efr Noncash Acquisition Of Convertible Note
NoncashAcquisitionOfConvertibleNote
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements in accordance with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. The Company must make these estimates and assumptions because certain information used is dependent on future events, cannot be calculated with a high degree of precision from data available or simply cannot be readily calculated based on generally accepted methodologies.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The more significant areas requiring the use of management estimates and assumptions relate to expectations of the future prices of uranium and REE as well as estimates of recoverable mineral resources that are the basis for future cash flow estimates utilized in assessing fair value for business combinations and impairment calculations; the determination of whether an acquisition represents a business combination or an asset acquisition; the use of management estimates and assumptions related to environmental, reclamation and closure obligations; marketable securities and derivative instruments; and share-based compensation expense. Actual results may differ significantly from these estimates.</span></div>
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
106791000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
675000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
107466000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
28159000 usd
CY2023Q4 efr Equity Securities Fvni Gross Unrealized Loss
EquitySecuritiesFVNIGrossUnrealizedLoss
2581000 usd
CY2023Q4 efr Equity Securities Fvni Gross Unrealized Gain
EquitySecuritiesFVNIGrossUnrealizedGain
0 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
25578000 usd
CY2023Q4 us-gaap Debt Securities Trading And Equity Securities Fv Ni Cost
DebtSecuritiesTradingAndEquitySecuritiesFvNiCost
134950000 usd
CY2023Q4 efr Debt Securities Trading And Equity Securities Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesTradingAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2581000 usd
CY2023Q4 efr Debt Securities Trading And Equity Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesTradingAndEquityAccumulatedGrossUnrealizedGainBeforeTax
675000 usd
CY2023Q4 us-gaap Trading Securities
TradingSecurities
133044000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11435000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
310000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
11125000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2876000 usd
CY2022Q4 efr Equity Securities Fvni Gross Unrealized Loss
EquitySecuritiesFVNIGrossUnrealizedLoss
1809000 usd
CY2022Q4 efr Equity Securities Fvni Gross Unrealized Gain
EquitySecuritiesFVNIGrossUnrealizedGain
0 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
1067000 usd
CY2022Q4 us-gaap Debt Securities Trading And Equity Securities Fv Ni Cost
DebtSecuritiesTradingAndEquitySecuritiesFvNiCost
14311000 usd
CY2022Q4 efr Debt Securities Trading And Equity Securities Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesTradingAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2119000 usd
CY2022Q4 efr Debt Securities Trading And Equity Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesTradingAndEquityAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q4 us-gaap Trading Securities
TradingSecurities
12192000 usd
CY2023Q4 efr Trade Receivables After Allowance For Credit Loss Current
TradeReceivablesAfterAllowanceForCreditLossCurrent
406000 usd
CY2022Q4 efr Trade Receivables After Allowance For Credit Loss Current
TradeReceivablesAfterAllowanceForCreditLossCurrent
92000 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
343000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
343000 usd
CY2023Q4 efr Other Receivables After Allowance For Credit Loss Current
OtherReceivablesAfterAllowanceForCreditLossCurrent
67000 usd
CY2022Q4 efr Other Receivables After Allowance For Credit Loss Current
OtherReceivablesAfterAllowanceForCreditLossCurrent
84000 usd
CY2023Q4 efr Receivables Net
ReceivablesNet
816000 usd
CY2022Q4 efr Receivables Net
ReceivablesNet
519000 usd
CY2014Q4 efr Numberof Note Receivables
NumberofNoteReceivables
2 note
CY2014Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1050000.00 usd
CY2018Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
500000 usd
CY2018Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
550000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
220000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
220000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
35807000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
35476000 usd
CY2023Q4 efr Inventory Of Ore In Stockpiles
InventoryOfOreInStockpiles
3072000 usd
CY2022Q4 efr Inventory Of Ore In Stockpiles
InventoryOfOreInStockpiles
940000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1841000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4204000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
40720000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
40620000 usd
CY2023Q4 efr Business Acquisition Number Of Common Stock Shares Acquired
BusinessAcquisitionNumberOfCommonStockSharesAcquired
8501424 shares
CY2023Q4 us-gaap Investments
Investments
1360000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
62048000 usd
CY2022 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
238000 usd
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1192000 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1556000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45836000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35925000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33174000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26123000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12662000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2750000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3270000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3190000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
119581000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
83539000 usd
CY2023Q1 efr Number Of Purchase Agreements
NumberOfPurchaseAgreements
2 purchaseagreement
CY2022Q2 efr Purchase Agreements Number Of Mineral Concessions Acquired
PurchaseAgreementsNumberOfMineralConcessionsAcquired
17 mineralconcession
CY2022Q2 efr Purchase Agreement Acres To Purchase
PurchaseAgreementAcresToPurchase
37300 acre
CY2022Q2 efr Purchase Agreement Miles To Purchase
PurchaseAgreementMilesToPurchase
58.3 mi
CY2022Q2 efr Purchase Agreements Number Of Mineral Concessions Acquired
PurchaseAgreementsNumberOfMineralConcessionsAcquired
17 mineralconcession
CY2022Q2 efr Purchase Agreement Purchase Price
PurchaseAgreementPurchasePrice
27500000 usd
CY2022Q2 efr Purchase Agreement Deposit Payment
PurchaseAgreementDepositPayment
5900000 usd
CY2023Q1 efr Purchase Agreement Payment Due At Closing
PurchaseAgreementPaymentDueAtClosing
21600000 usd
CY2023Q4 efr Purchase Agreement Direct Deal Costs
PurchaseAgreementDirectDealCosts
1630000 usd
CY2022 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
3590000 usd
CY2022 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
3590000 usd
CY2021Q4 efr Disposal Group Shares Received In Transaction
DisposalGroupSharesReceivedInTransaction
11860101 shares
CY2021Q4 efr Disposal Group Shares Received In Transaction Price Per Share
DisposalGroupSharesReceivedInTransactionPricePerShare
2.95
CY2021Q4 efr Disposal Group Production Payment Commitment
DisposalGroupProductionPaymentCommitment
5000000 cad
CY2021Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
35730000 usd
CY2021Q4 us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
270000 usd
CY2021Q4 efr Disposal Group Shares Received In Transaction
DisposalGroupSharesReceivedInTransaction
1875085 shares
CY2021Q4 efr Disposal Group Warrants Issued
DisposalGroupWarrantsIssued
937542 shares
CY2021Q4 efr Disposal Group Warrants Issued Price Per Share
DisposalGroupWarrantsIssuedPricePerShare
4.00
CY2021Q4 efr Disposal Group Proceeds For Payment Agreement
DisposalGroupProceedsForPaymentAgreement
1970000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
9595000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
13687000 usd
CY2023 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-214000 usd
CY2023 efr Asset Retirement Obligation Held For Sale
AssetRetirementObligationHeldForSale
0 usd
CY2022 efr Asset Retirement Obligation Held For Sale
AssetRetirementObligationHeldForSale
5410000 usd
CY2023 efr Asset Retirement Obligation Disposal Of Non Core Obligations
AssetRetirementObligationDisposalOfNonCoreObligations
79000 usd
CY2022 efr Asset Retirement Obligation Disposal Of Non Core Obligations
AssetRetirementObligationDisposalOfNonCoreObligations
0 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
10922000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
9595000 usd
CY2023Q4 efr Undiscounted Decommissioning Liability
UndiscountedDecommissioningLiability
33380000 usd
CY2022Q4 efr Undiscounted Decommissioning Liability
UndiscountedDecommissioningLiability
42910000 usd
CY2023 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-210000 usd
CY2022 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
240000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17449000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
20305000 usd
CY2023Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
130000 usd
CY2022Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
734000 usd
CY2023 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
0 usd
CY2022 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
3590000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17579000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17449000 usd
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
149807 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
157682531 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
156262199 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134311033 shares
CY2023 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
105819 shares
CY2022 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
155509 shares
CY2021 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
474072 shares
CY2023 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
290390 shares
CY2022 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
335546 shares
CY2021 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
443364 shares
CY2023 efr Stock Issued During Period Shares Stock Appreciation Rights Vested
StockIssuedDuringPeriodSharesStockAppreciationRightsVested
120291 shares
CY2022 efr Stock Issued During Period Shares Stock Appreciation Rights Vested
StockIssuedDuringPeriodSharesStockAppreciationRightsVested
2679 shares
CY2021 efr Stock Issued During Period Shares Stock Appreciation Rights Vested
StockIssuedDuringPeriodSharesStockAppreciationRightsVested
2316 shares
CY2023 efr Stock Issued For Exercise Of Warrants
StockIssuedForExerciseOfWarrants
0 shares
CY2022 efr Stock Issued For Exercise Of Warrants
StockIssuedForExerciseOfWarrants
0 shares
CY2021 efr Stock Issued For Exercise Of Warrants
StockIssuedForExerciseOfWarrants
1737981 shares
CY2023 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
42202 shares
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
16064 shares
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
35933 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159107039 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157343250 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146904524 shares
CY2023 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
99862000 usd
CY2022 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-59849000 usd
CY2021 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1541000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159107039 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157343250 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146904524 shares
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1047001 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2816593 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160154040 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157343250 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149721117 shares
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.63
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.38
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.62
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.38
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
110000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
60000.00 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6870000 shares
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4625000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4641000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2158000 usd
CY2023 efr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodIntrinsicValue
3550000 usd
CY2022 efr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodIntrinsicValue
50000.00 usd
CY2021 efr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodIntrinsicValue
260000 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1609087 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.91
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
169310 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.99
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
775814 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.95
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8048 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.16
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
51653 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.14
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
942882 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.79
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
118318 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.52
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
256315 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.93
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
20700 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.91
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
16507 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.52
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
767678 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.24
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
153299 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.20
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
348538 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.83
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
32250 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.74
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
16720 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.75
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
523469 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.48
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M21D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1448000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
354286 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.24
CY2023 efr Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Instant
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermInstant
P1Y6M18D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1400000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1530000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2230000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2880000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100032000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59944000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1448000 usd
CY2023Q4 efr Deferred Tax Assets Mineral Properties And Deferred Costs Canada
DeferredTaxAssetsMineralPropertiesAndDeferredCostsCanada
1726000 usd
CY2022Q4 efr Deferred Tax Assets Mineral Properties And Deferred Costs Canada
DeferredTaxAssetsMineralPropertiesAndDeferredCostsCanada
1815000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
2894000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
3976000 usd
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
986000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1079000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
119755000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
146931000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
119755000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100032000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59944000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1448000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
26508000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-15885000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
384000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-893000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
572000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-89000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
2015000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
3977000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
159000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-27354000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11336000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-454000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
276000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
547000 usd
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
5984000 usd
CY2023Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
209000 usd
CY2022Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
209000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
93241000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
108827000 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
849000 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
881000 usd
CY2023Q4 efr Deferred Tax Assets Deferred Incomeand Other Noncurrent
DeferredTaxAssetsDeferredIncomeandOtherNoncurrent
2431000 usd
CY2022Q4 efr Deferred Tax Assets Deferred Incomeand Other Noncurrent
DeferredTaxAssetsDeferredIncomeandOtherNoncurrent
5433000 usd
CY2023Q4 efr Deferred Tax Assets Mineral Properties And Deferred Costs United States
DeferredTaxAssetsMineralPropertiesAndDeferredCostsUnitedStates
16872000 usd
CY2022Q4 efr Deferred Tax Assets Mineral Properties And Deferred Costs United States
DeferredTaxAssetsMineralPropertiesAndDeferredCostsUnitedStates
18727000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
146931000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023 efr Valuation Allowance Deferred Tax Asset Additions Amount
ValuationAllowanceDeferredTaxAssetAdditionsAmount
0 usd
CY2023 efr Valuation Allowance Deferred Tax Asset Deductions Amount
ValuationAllowanceDeferredTaxAssetDeductionsAmount
27176000 usd
CY2022 efr Valuation Allowance Deferred Tax Asset Additions Amount
ValuationAllowanceDeferredTaxAssetAdditionsAmount
11927000 usd
CY2022 efr Valuation Allowance Deferred Tax Asset Deductions Amount
ValuationAllowanceDeferredTaxAssetDeductionsAmount
499000 usd
CY2023 us-gaap Revenues
Revenues
37928000 usd
CY2022 us-gaap Revenues
Revenues
12515000 usd
CY2021 us-gaap Revenues
Revenues
3184000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
406000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
92000 usd
CY2023 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
15472000 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-10491000 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-530000 usd
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-456000 usd
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
795000 usd
CY2023 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
1141000 usd
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2023 efr Debt Securities Fvni Gain Loss
DebtSecuritiesFVNIGainLoss
1430000 usd
CY2022 efr Debt Securities Fvni Gain Loss
DebtSecuritiesFVNIGainLoss
0 usd
CY2021 efr Debt Securities Fvni Gain Loss
DebtSecuritiesFVNIGainLoss
0 usd
CY2023 efr Change In Value Of Warrant Liabilities
ChangeInValueOfWarrantLiabilities
0 usd
CY2022 efr Change In Value Of Warrant Liabilities
ChangeInValueOfWarrantLiabilities
0 usd
CY2021 efr Change In Value Of Warrant Liabilities
ChangeInValueOfWarrantLiabilities
-8078000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
423000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2058000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-128000 usd
CY2023 efr Department Of Energy Award
DepartmentOfEnergyAward
0 usd
CY2022 efr Department Of Energy Award
DepartmentOfEnergyAward
0 usd
CY2021 efr Department Of Energy Award
DepartmentOfEnergyAward
1900000 usd
CY2023 efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
5697000 usd
CY2022 efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
-166000 usd
CY2021 efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
340000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13142000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15372000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1140000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1006000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1850000 usd
CY2023Q4 efr Accrued Operating Expense
AccruedOperatingExpense
4391000 usd
CY2022Q4 efr Accrued Operating Expense
AccruedOperatingExpense
1783000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4162000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2929000 usd
CY2023Q4 efr Accrued Capital Expenditures
AccruedCapitalExpenditures
205000 usd
CY2022Q4 efr Accrued Capital Expenditures
AccruedCapitalExpenditures
22000 usd
CY2023Q4 efr Accrued Property Taxes
AccruedPropertyTaxes
393000 usd
CY2022Q4 efr Accrued Property Taxes
AccruedPropertyTaxes
240000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
105000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10161000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6929000 usd
CY2023Q4 efr Convertible Note Receivable Redeemed
ConvertibleNoteReceivableRedeemed
40000000 usd
CY2023Q4 efr Convertible Notes Receivable Sold
ConvertibleNotesReceivableSold
20000000 usd
CY2023Q4 efr Convertible Note Receivable Consideration Received
ConvertibleNoteReceivableConsiderationReceived
21000000 usd
CY2023Q4 efr Convertible Note Receivable Unpaid Accrued Interest
ConvertibleNoteReceivableUnpaidAccruedInterest
1500000 usd
CY2023Q4 efr Convertible Note Receivable Sales Commission
ConvertibleNoteReceivableSalesCommission
100000 usd
CY2023Q4 efr Proceeds From Convertible Note Receivable
ProceedsFromConvertibleNoteReceivable
22400000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
60887000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
1430000 usd
CY2023Q4 efr Trade Receivables After Allowance For Credit Loss Current
TradeReceivablesAfterAllowanceForCreditLossCurrent
410000 usd
CY2022Q4 efr Trade Receivables After Allowance For Credit Loss Current
TradeReceivablesAfterAllowanceForCreditLossCurrent
90000.00 usd
CY2023 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
80000.00 usd
CY2022 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
130000 usd
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
310000 usd
CY2023Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1530000 usd
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1540000 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001385849-24-000025-index-headers.html Edgar Link pending
0001385849-24-000025-index.html Edgar Link pending
0001385849-24-000025.txt Edgar Link pending
0001385849-24-000025-xbrl.zip Edgar Link pending
efr-20231231.htm Edgar Link pending
efr-20231231.xsd Edgar Link pending
efr-20231231_g1.jpg Edgar Link pending
efr-20231231_g10.jpg Edgar Link pending
efr-20231231_g11.jpg Edgar Link pending
efr-20231231_g12.jpg Edgar Link pending
efr-20231231_g13.jpg Edgar Link pending
efr-20231231_g14.jpg Edgar Link pending
efr-20231231_g15.jpg Edgar Link pending
efr-20231231_g16.jpg Edgar Link pending
efr-20231231_g17.jpg Edgar Link pending
efr-20231231_g18.jpg Edgar Link pending
efr-20231231_g19.jpg Edgar Link pending
efr-20231231_cal.xml Edgar Link unprocessable
efr-20231231_def.xml Edgar Link unprocessable
efr-20231231_g2.jpg Edgar Link pending
efr-20231231_g20.jpg Edgar Link pending
efr-20231231_g21.jpg Edgar Link pending
efr-20231231_g22.jpg Edgar Link pending
efr-20231231_g23.jpg Edgar Link pending
efr-20231231_g3.jpg Edgar Link pending
efr-20231231_g4.jpg Edgar Link pending
efr-20231231_g5.jpg Edgar Link pending
efr-20231231_g6.jpg Edgar Link pending
efr-20231231_g7.jpg Edgar Link pending
efr-20231231_g8.jpg Edgar Link pending
efr-20231231_g9.jpg Edgar Link pending
efr12312023-ex211.htm Edgar Link pending
efr12312023-ex231.htm Edgar Link pending
efr12312023-ex2310.htm Edgar Link pending
efr12312023-ex2311.htm Edgar Link pending
efr12312023-ex2312.htm Edgar Link pending
efr12312023-ex2313.htm Edgar Link pending
efr12312023-ex2314.htm Edgar Link pending
efr12312023-ex232.htm Edgar Link pending
efr12312023-ex233.htm Edgar Link pending
efr12312023-ex234.htm Edgar Link pending
efr12312023-ex235.htm Edgar Link pending
efr12312023-ex236.htm Edgar Link pending
efr12312023-ex237.htm Edgar Link pending
efr12312023-ex238.htm Edgar Link pending
efr12312023-ex239.htm Edgar Link pending
efr12312023-ex311.htm Edgar Link pending
efr12312023-ex312.htm Edgar Link pending
efr12312023-ex321.htm Edgar Link pending
efr12312023-ex322.htm Edgar Link pending
efr12312023-ex42.htm Edgar Link pending
efr12312023-ex951.htm Edgar Link pending
efr12312023-ex991.htm Edgar Link pending
efr12312023-exx141.htm Edgar Link pending
efr12312023-exx191.htm Edgar Link pending
efr12312023-exx971.htm Edgar Link pending
efriheading1a.jpg Edgar Link pending
efriheadinga.jpg Edgar Link pending
entityorganizationchart_fe.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
kpmg.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
efr-20231231_pre.xml Edgar Link unprocessable
efr-20231231_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slrlogo.jpg Edgar Link pending
slrlogo1.jpg Edgar Link pending
slrlogo2.jpg Edgar Link pending
slrlogo3.jpg Edgar Link pending
slrlogo4.jpg Edgar Link pending
slrlogo5.jpg Edgar Link pending
woods.jpg Edgar Link pending
efr-20231231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable